Cancer Australia has engaged ORIMA Research to deliver the fourth national audit of cancer research funding and key funding drivers report, by undertaking an audit of cancer research funding across the period of 2021-2023 combined with a desktop review and analysis of the key drivers for cancer research patterns and funding over this period.

This is the latest observation of this contract, and the explorer’s totals use its value.

$190,784.00

Full reported contract value · AUD including applicable GST · 2026-03-03 to 2026-08-14

Reporting agency: Cancer Australia
Reported supplier: ORIMA Research Pty Ltd
Reported ABN: 77 076 347 914. Exemption as supplied: No.
Category: Research programs
Procurement method: Open tender
Original publication: 2026-03-23 14:50:00 (ACT local time as supplied)
Amendment publication: 2026-07-07 09:55:00 (ACT local time as supplied)
Amendment reason: Variation to contract value
Agency reference: PO1472
Approach to market / standing offer: ATM not supplied / SON3352211
Consultancy: No
Confidentiality as reported: Contract: No; outputs: No
Source observation: CN4227279-A1 · Official weekly workbook ending 2026-07-11 · sheet “Contract Notice Export”, row 586.

The original register may now show later corrections. The card and this observation keep the saved source date.